ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Flurazepam Hydrochloride Capsule shortage

Current  6 presentations · 2 manufacturers · first FDA posting 2022-08-03 · last update 2026-09-15

Manufacturers: Chartwell Molecular Holdings LLC, Rising Pharma Holdings, Inc.

Stated reasons (per FDA): Regulatory delay

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30)Chartwell Molecular Holdings LLCCurrent
Available
 —Posted 08/03/2022
Updated 09/15/2026
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)Chartwell Molecular Holdings LLCCurrent
Available
 —Posted 08/03/2022
Updated 09/15/2026
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30)Chartwell Molecular Holdings LLCCurrent
Available
 —Posted 08/03/2022
Updated 09/15/2026
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)Chartwell Molecular Holdings LLCCurrent
Available
 —Posted 08/03/2022
Updated 09/15/2026
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)Rising Pharma Holdings, Inc.Current
Unavailable
 Regulatory delayAnticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.Posted 08/03/2022
Updated 09/01/2026
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)Rising Pharma Holdings, Inc.Current
Unavailable
 Regulatory delayAnticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.Posted 08/03/2022
Updated 09/01/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)